CKD and the risk of incident cancer

Journal of the American Society of Nephrology

Volumn 25, Issue 10, 2014, Pages 2327-2334

  Lowrance, William T ^a   Ordoñez, Juan ^b   Udaltsova, Natalia ^c   Russo, Paul ^d   Go, Alan S ^c,e,f  

^a UNIVERSITY OF UTAH   (United States)

^b KAISER PERMANENTE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE DELIVERY; HUMAN; KIDNEY CARCINOMA; KIDNEY FUNCTION; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; VERY ELDERLY; COMPLICATION; INCIDENCE; KIDNEY NEOPLASMS; NEOPLASMS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84921725303     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060604     Document Type: Article

References (43)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
2. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012
3. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
4. Cengiz K: Increased incidence of neoplasia in chronic renal failure (20-year experience). Int Urol Nephrol 33: 121-126, 2002
5. Holley JL: Screening, diagnosis, and treatment of cancer in long-term dialysis patients. Clin J Am Soc Nephrol 2: 604-610, 2007
6. Iseki K, Osawa A, Fukiyama K: Evidence for increased cancer deaths in chronic dialysis patients. Am J Kidney Dis 22: 308-313, 1993
7. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P: Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 354: 93-99, 1999
8. Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, Najarian JS: Increased incidence of malignancy during chronic renal failure. Lancet 1: 883-886, 1975
9. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM: Neoplasms in dialysis patients: A population-based study. Am J Kidney Dis 14: 119-123, 1989
10. Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB, Disney AP, Wolfe RA, Boyle P, Maisonneuve P: Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: Analysis of data fromthe United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14: 197-207, 2003
11. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE: Cancer incidence before and after kidney transplantation. JAMA 296: 2823-2831, 2006
12. Christensson A, Savage C, Sjoberg DD, Cronin AM, Frank O'Brien M, Lowrance W, Nilsson PM, Vickers AJ, Russo P, Lilja H: Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years. Int J Cancer 133: 1452-1458, 2013
13. Jørgensen L, Heuch I, Jenssen T, Jacobsen BK: Association of albuminuria and cancer incidence. J Am Soc Nephrol 19: 992-998, 2008
14. Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC: Association of CKD and cancer risk in older people. J Am Soc Nephrol 20: 1341-1350, 2009
15. Wong G, Zoungas S, Lo S, Chalmers J, Cass A, Neal B, Woodward M, Perkovic V, Glasziou P, Williams B, Howard K, Chapman JR, Craig JC: The risk of cancer in people with diabetes and chronic kidney disease. Nephrol Dial Transplant 27: 3337-3344, 2012
16. Weng PH, Hung KY, Huang HL, Chen JH, Sung PK, Huang KC: Cancer-specific mortality in chronic kidney disease: Longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6: 1121-1128, 2011
17. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J: The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140: 9-17, 2004
18. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insuf ficiency. Circulation 107: 87-92, 2003
19. Coussens LM, Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002
20. Giacchino F, Alloatti S, Quarello F, Bosticardo GM, Giraudo G, Piccoli G: The immunological state in chronic renal insuf ficiency. Int J Artif Organs 5: 237-242, 1982
21. Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH: Antihypertensive drugs and risk of cancer: Network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol 12: 65-82, 2011
22. Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, Wallace RB, Havlik RJ: Calcium-channel blockade and incidence of cancer in aged populations. Lancet 348: 493-497, 1996
23. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group: Effect of dutasteride on the risk of prostate cancer. N Engl J Med 362: 1192-1202, 2010
24. Liu W, Choueiri TK, Cho E: Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts. Cancer 118: 797-803, 2012
25. Taylor ML, Wells BJ, Smolak MJ: Statins and cancer: A meta-analysis of case-control studies. Eur J Cancer Prev 17: 259-268, 2008
26. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr.: The influence of finasteride on the development of prostate cancer. NEngl JMed 349: 215-224, 2003
27. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen C-P, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium: Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular fi ltration rate. JAMA 307: 1941-1951, 2012
28. Fireman BH, Fehrenbacher L, Gruskin EP, Ray GT: Cost of care for patients in cancer clinical trials. J Natl Cancer Inst 92: 136-142, 2000
29. Dubach UC, Rosner B, Stürmer T: An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987). N Engl JMed 324: 155-160, 1991
30. Lornoy W, Becaus S, de Vleeschouwer M, Morelle V, Fonteyne E, Thienpoint L, Mestdagh J: Renal cell carcinoma, a new complication of analgesic nephropathy. Lancet 1: 1271-1272, 1986
31. Cho E, Curhan G, Hankinson SE, Kantoff P, Atkins MB, Stampfer M, Choueiri TK: Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med 171: 1487-1493, 2011
32. Krieger N: Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 82: 703-710, 1992
33. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40[Suppl]: IV-3-IV-18, 2002
34. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
35. Arellano MG, Petersen GR, Petitti DB, Smith RE: The California Automated Mortality Linkage System (CAMLIS). Am J Public Health 74: 1324-1330, 1984
36. Newman TB, Brown AN: Use of commercial record linkage software and vital statistics to identify patient deaths. J AmMed Inform Assoc 4: 233-237, 1997
37. Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH: Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA 296: 2105-2111, 2006
38. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV: Ethnic disparities in diabetic complications in an insured population. JAMA 287: 2519-2527, 2002
39. Selby JV, Ray GT, Zhang D, Colby CJ: Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20: 1396-1402, 1997
40. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS: Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362: 2155-2165, 2010
41. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ: Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363: 2211-2219, 2010
42. Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R: Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med 168: 2415-2421, 2008
43. Therneau TM, Grambsch PM: Modeling Survival Data: Extending the Cox Model, New York, Springer-Verlag, 2000